Sfoglia per Autore
Prospective Evaluation of a Model-Based approach to select Phase 1 Dosing Regimen for MEN1309/OBT076, a novel antibody drug conjugate (ADC) targeting Ly75 antigen for the treatment of CD205-positive metastatic solid tumours and Non-Hodgkin lymphoma
2019-01-01 Borella, E.; Mazzei, P.; Piana, C.; Tagliavini, A.; Magni, P.; Buontempo, S.; Tagliacozzi, D.; Fedi, V.; Capriati, A.; Pellacani, A.
Use of prior knowledge and extrapolation in paediatric drug development: a case study with deferasirox
2019-01-01 Borella, E.; Oosterholt, S.; Magni, P.; Della Pasqua, O.
Characterisation of individual ferritin response in patients receiving chelation therapy
2022-01-01 Borella, E.; Oosterholt, S.; Magni, P.; Della Pasqua, O.
Model-based prediction of effective target exposure for MEN1611 in combination with trastuzumab in HER2-positive advanced or metastatic breast cancer patients
2023-01-01 Tosca, E. M.; Borella, E.; Piana, C.; Bouchene, S.; Merlino, G.; Fiascarelli, A.; Mazzei, P.; Magni, P.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile